Patient resources
Efficacy of antiplatelets in deep venous thrombosis
Venous thromboembolism (VTE) is the third most common cardiovascular disease in the world. Every year, 30,000 people in Australia develop VTE, at a cost of $1.72 billion to the Australian health system.
Lead-up to medicine error
Mr Sotirios Temopoulos had a medical history that included multiple myeloma with a myelomataus lesion in his cervical spine, in which he was prescribed...
Psychotropic self-poisoning on the rise in youth
A new retrospective cohort study has found that self-poisoning, by ingesting psychotropic medicines, in Australian children and adolescents is increasing. The prescribed medicines...
Pharmacy Board’s measured step on prescribing
The Pharmacy Board of Australia has recognised that pharmacists should be able to prescribe under two monitored models of prescribing, in a move welcomed...
PSA National President opening address at PSA24
Read the transcript of the speech delivered by PSA National President Associate Professor Fei Sim FPS at PSA24 today (2 August).
Antimicrobial use up in disadvantaged areas
Antimicrobial medicines use declined in Australia from 2013 to 2018, but the country’s rate remains high by OECD standards, according to new research.
